The World Health
Organization (WHO) on Sunday, said it has stopped the use of hydroxychloroquine
and lopinavir/ritonavir for COVID-19 trial treatment.
This follows the
result of its interim trial, which showed that the drugs produce little or no
reduction in the mortality of patients.
In a press
statement, the health agency confirmed it had established the solidarity trial
to come up with effective COVID-19 treatment for hospitalized patients.
WHO also noted that
it “accepted the recommendation” from the International Steering Committee to
discontinue the trial for hydroxychloroquine, as well as HIV/AIDS medications
lopinavir and ritonavir.
According to WHO,
the solidarity trial investigators will stop the trials immediately.
“For each of the
drugs, the interim results do not provide solid evidence of increased
mortality. There were, however, some associated safety signals in the clinical
laboratory findings of the add-on Discovery trial, a participant in the
Solidarity trial. These will also be reported in the peer-reviewed
publication.”
WHO has said June
was the most devastating month for the COVID-19 pandemic, with more than
180,000 cases recorded in a day on four occasions and total deaths exceeded
500,000.
The pandemic is now
in its sixth month and has affected 213 countries and territories globally.
Click to signup for FREE news updates, latest information and hottest gists everyday
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com